Key facts
- 52-week range (closes)
- $100.27 – $483.02 Lowest close Mar 30, 2026, highest Jun 30, 2026; 251 daily closes to Oct 13, 2026 from Dalsna Finance's price archive
- Fiscal year ends
- December Fiscal 2025 ended Dec 31, 2025, from SEC filings
- In the Nasdaq-100 since
- Jun 22, 2026, replacing Charter Communications (CHTR), Cognizant (CTSH), Insmed Incorporated (INSM), Verisk Analytics (VRSK) and Zscaler (ZS) · Quarterly index reconstitution. Nasdaq-100 moved to a regular quarterly rebalancing schedule. · All Nasdaq-100 changes
- IPO
- Mar 20, 2024 · priced at $36.00 · NASDAQ · IPO details
Astera Labs (ALAB) is trading down at $284.80 (-0.62%) on NASDAQ, as of the latest quote. It is a Nasdaq-100 constituent in the Information Technology sector.
Astera Labs revenue & net income history (FY2022–FY2025)
| FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $79.9M | $115.8M | $396.3M | $852.5M |
| Growth (year over year) | — | +45.0% | +242.2% | +115.1% |
| Gross profit | $58.7M | $79.8M | $302.7M | $645.3M |
| Gross margin | 73.5% | 68.9% | 76.4% | 75.7% |
| Operating income | −$60.2M | −$29.5M | −$116.1M | $173.4M |
| Operating margin | −75.4% | −25.5% | −29.3% | 20.3% |
| Net income | −$58.3M | −$26.3M | −$83.4M | $219.1M |
| Net margin | −73.0% | −22.7% | −21.1% | 25.7% |
| EPS (diluted) | −$1.71 | −$0.71 | −$0.64 | $1.22 |
| Balance sheet | ||||
| Cash and equivalents | $76.1M | $45.1M | $79.6M | $167.6M |
| Total assets | — | $196.3M | $1.05B | $1.53B |
| Total liabilities | — | $38.9M | $89.7M | $168.2M |
| Shareholders' equity | −$85.3M | −$97.7M | $964.8M | $1.36B |
| Cash flow | ||||
| Operating cash flow | −$35.9M | −$12.7M | $136.7M | $319.3M |
| Capital expenditure | $3.87M | $2.76M | $34.2M | $37.5M |
| Free cash flow | −$39.8M | −$15.5M | $102.4M | $281.8M |
| Share buybacks | $313.0K | $210.0K | $1.07M | $0 |
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $113.1M | $141.1M | $159.4M | $191.9M | $230.6M | $270.6M | $308.4M | $392.4M |
| Growth (year over year) | +206.2% | +179.3% | +144.3% | +149.7% | +103.9% | +91.8% | +93.4% | +104.5% |
| Gross profit | $87.9M | $104.4M | $119.4M | $145.6M | $175.8M | $204.5M | $235.1M | $287.6M |
| Gross margin | 77.7% | 74.0% | 74.9% | 75.8% | 76.2% | 75.6% | 76.3% | 73.3% |
| Operating income | −$8.90M | $144.0K | $11.3M | $39.8M | $55.4M | $67.0M | $61.8M | $89.2M |
| Operating margin | −7.9% | 0.1% | 7.1% | 20.7% | 24.0% | 24.7% | 20.1% | 22.7% |
| Net income | −$7.59M | $24.7M | $31.8M | $51.2M | $91.1M | $45.0M | $80.3M | $153.1M |
| Net margin | −6.7% | 17.5% | 20.0% | 26.7% | 39.5% | 16.6% | 26.0% | 39.0% |
| EPS (diluted) | −$0.05 | $1.23 | $0.18 | $0.29 | $0.50 | $0.25 | $0.44 | $0.83 |
| Balance sheet | ||||||||
| Cash and equivalents | $126.1M | $79.6M | $86.4M | $162.3M | $140.4M | $167.6M | $148.3M | $111.5M |
| Total assets | $983.1M | $1.05B | $1.12B | $1.27B | $1.40B | $1.53B | $1.66B | $1.93B |
| Total liabilities | $93.5M | $89.7M | $80.1M | $135.7M | $129.5M | $168.2M | $165.3M | $205.8M |
| Shareholders' equity | $889.6M | $964.8M | $1.04B | $1.14B | $1.27B | $1.36B | $1.49B | $1.73B |
| Cash flow | ||||||||
| Operating cash flow | $63.5M | $39.7M | $10.5M | $135.4M | $78.2M | $95.3M | $74.6M | $87.7M |
| Capital expenditure | $16.7M | $15.4M | $4.54M | $2.02M | $12.3M | $18.7M | $7.59M | $20.5M |
| Free cash flow | $46.8M | $24.3M | $5.96M | $133.3M | $65.9M | $76.6M | $67.0M | $67.2M |
From Astera Labs's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
About Astera Labs
Astera Labs, Inc., headquartered in San Jose, California, is a fabless manufacturing company that develops connectivity technologies and related software that are used in data centers serving the artificial intelligence and cloud-computing markets. Its products include the Aries PCIe/Compute Express Link (CXL) smart DSP retimers, which extend the physical reach and improve signal integrity for PCI Express connections in large server clusters; Scorpio smart fabric switches, which provide high-bandwidth GPU-to-GPU interconnects and manage traffic inside AI racks; Taurus ethernet smart cable modules, which advance high-speed ethernet networking infrastructure over copper links; and Leo CXL memory controllers, which facilitate high-speed memory expansion and memory pooling for memory-heavy workloads.
Source: Wikipedia — Astera Labs
- Headquarters
- San Jose, California From SEC filings, Oct 2026
Recent News (1)
More Information Technology stocks
- ADBE Adobe Inc.
- ADI Analog Devices
- ADSK Autodesk
- AKAM Akamai Technologies
- AMAT Applied Materials
- AMD Advanced Micro Devices
- ANET Arista Networks
- APH Amphenol